Phyllis M. Goddard

1.8k total citations
30 papers, 1.4k citations indexed

About

Phyllis M. Goddard is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Phyllis M. Goddard has authored 30 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Organic Chemistry, 13 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in Phyllis M. Goddard's work include Metal complexes synthesis and properties (8 papers), Synthesis and Biological Evaluation (6 papers) and Click Chemistry and Applications (5 papers). Phyllis M. Goddard is often cited by papers focused on Metal complexes synthesis and properties (8 papers), Synthesis and Biological Evaluation (6 papers) and Click Chemistry and Applications (5 papers). Phyllis M. Goddard collaborates with scholars based in United Kingdom, France and Italy. Phyllis M. Goddard's co-authors include Barry A. Murrer, Michael Jarman, Kenneth R. Harrap, Melanie Valenti, Florence I. Raynaud, Lloyd R. Kèlland, Mitch Dowsett, Gerard A. Potter, S. Elaine Barrie and Benjamin P. Haynes and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Annals of Oncology.

In The Last Decade

Phyllis M. Goddard

30 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Phyllis M. Goddard United Kingdom	20	695	518	486	255	157	30	1.4k
Lee D. Arnold United States	18	540 0.8×	1.1k 2.2×	493 1.0×	287 1.1×	63 0.4×	37	1.9k
M. F. G. STEVENS United Kingdom	22	648 0.9×	1.3k 2.5×	622 1.3×	475 1.9×	78 0.5×	62	2.8k
John S. Tokarski United States	23	438 0.6×	776 1.5×	690 1.4×	105 0.4×	103 0.7×	43	2.0k
Amarnath Natarajan United States	28	585 0.8×	1.6k 3.2×	748 1.5×	243 1.0×	74 0.5×	99	2.8k
Gregory D. Vite United States	28	1.1k 1.6×	1.3k 2.5×	1.0k 2.2×	206 0.8×	51 0.3×	64	2.8k
Jennifer J. Bouska United States	23	643 0.9×	1.1k 2.0×	851 1.8×	67 0.3×	92 0.6×	41	2.1k
Pierre Deprez Belgium	18	263 0.4×	533 1.0×	445 0.9×	318 1.2×	50 0.3×	58	1.4k
Steven K. Davidsen United States	31	702 1.0×	1.9k 3.6×	1000 2.1×	107 0.4×	63 0.4×	80	3.0k
Ute Hoch United States	26	971 1.4×	858 1.7×	244 0.5×	268 1.1×	41 0.3×	86	2.1k
Wim F. A. Steelant United States	22	344 0.5×	1.1k 2.0×	753 1.5×	199 0.8×	436 2.8×	35	2.5k

Countries citing papers authored by Phyllis M. Goddard

Since Specialization

Citations

This map shows the geographic impact of Phyllis M. Goddard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phyllis M. Goddard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phyllis M. Goddard more than expected).

Fields of papers citing papers by Phyllis M. Goddard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phyllis M. Goddard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phyllis M. Goddard. The network helps show where Phyllis M. Goddard may publish in the future.

Co-authorship network of co-authors of Phyllis M. Goddard

This figure shows the co-authorship network connecting the top 25 collaborators of Phyllis M. Goddard. A scholar is included among the top collaborators of Phyllis M. Goddard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phyllis M. Goddard. Phyllis M. Goddard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nutley, Bernard, Florence I. Raynaud, Stuart C. Wilson, et al.. (2005). Metabolism and pharmacokinetics of the cyclin-dependent kinase inhibitorR-roscovitine in the mouse. Molecular Cancer Therapeutics. 4(1). 125–139. 25 indexed citations

Nutley, Bernard, Florence I. Raynaud, Stuart C. Wilson, et al.. (2005). Metabolism and pharmacokinetics of the cyclin-dependent kinase inhibitor R-roscovitine in the mouse.. PubMed. 4(1). 125–39. 58 indexed citations

Raynaud, Florence I., Rosanne M. Orr, Phyllis M. Goddard, et al.. (1997). Pharmacokinetics of G3139, a Phosphorothioate Oligodeoxynucleotide Antisense to bcl-2, after Intravenous Administration or Continuous Subcutaneous Infusion to Mice. Journal of Pharmacology and Experimental Therapeutics. 281(1). 420–427. 98 indexed citations

Barrie, S. Elaine, Benjamin P. Haynes, Gerard A. Potter, et al.. (1997). Biochemistry and pharmacokinetics of potent non-steroidal cytochrome P45017α inhibitors. The Journal of Steroid Biochemistry and Molecular Biology. 60(5-6). 347–351. 26 indexed citations

Coley, Helen M., Michael Jarman, Natalie Brooks, et al.. (1996). Pre-clinical development of the anti-tumour agent CB 7646,BIS N-(hydroxymethyl) trimethylmelamine, a stable analogue of trimelamol. International Journal of Cancer. 68(3). 356–363. 2 indexed citations

Walton, Michael I., Phyllis M. Goddard, Lloyd R. Kèlland, David E. Thurston, & Kenneth R. Harrap. (1996). Preclinical pharmacology and antitumour activity of the novel sequence-selective DNA minor-groove cross-linking agent DSB-120. Cancer Chemotherapy and Pharmacology. 38(5). 431–438. 23 indexed citations

Jarman, Michael, et al.. (1996). The activity of N-(hydroxymethyl) melamines in fresh human ovarian tumour cells and xenografts.. PubMed. 16(4A). 1851–5. 3 indexed citations

Kelland, Lloyd R., I. G. Evans, Barry A. Murrer, et al.. (1995). Synthesis and in Vitro and in Vivo Antitumor Activity of a Series of Trans Platinum Antitumor Complexes. Journal of Medicinal Chemistry. 38(16). 3016–3024. 74 indexed citations

Knox, Richard J., Frank Friedlos, Michael Jarman, et al.. (1995). Virtual cofactors for an Escherichia coli nitroreductase enzyme: Relevance to reductively activated prodrugs in antibody directed enzyme prodrug therapy (ADEPT). Biochemical Pharmacology. 49(11). 1641–1647. 29 indexed citations

10.

Kèlland, Lloyd R., C. F. J. Barnard, Kirste Mellish, et al.. (1994). A novel trans-platinum coordination complex possessing in vitro and in vivo antitumor activity.. PubMed. 54(21). 5618–22. 116 indexed citations

11.

Barrie, S. Elaine, Gerard A. Potter, Phyllis M. Goddard, et al.. (1994). Pharmacology of novel steroidal inhibitors of cytochrome P45017 (17α-hydroxylase/C17–20 lyase). The Journal of Steroid Biochemistry and Molecular Biology. 50(5-6). 267–273. 206 indexed citations

12.

Goddard, Phyllis M., et al.. (1994). The role of glutathione (GSH) in determining sensitivity to platinum drugs in vivo in platinum-sensitive and -resistant murine leukaemia and plasmacytoma and human ovarian carcinoma xenografts.. PubMed. 14(3A). 1065–70. 10 indexed citations

13.

Knox, Richard J., Frank Friedlos, Patrick J. Biggs, et al.. (1993). Identification, synthesis and properties of 5-(aziridin-1-YL)-2-nitro-4-nitrosobenzamide, A novel DNA crosslinking agent derived from CB1954. Biochemical Pharmacology. 46(5). 797–803. 23 indexed citations

14.

Goddard, Phyllis M., Melanie Valenti, & Kenneth R. Harrap. (1991). The role of murine tumour models and their acquired platinum-resistant counterparts in the evaluation of novel platinum antitumour agents: A cautionary note. Annals of Oncology. 2(8). 535–540. 21 indexed citations

15.

Kelland, Lloyd R., Mervyn Jones, Phyllis M. Goddard, et al.. (1991). Platinum coordination complexes which circumvent cisplatin resistance. Advances in Enzyme Regulation. 31. 31–43. 17 indexed citations

16.

Goddard, Phyllis M., et al.. (1990). The 5-HT3 antagonist, BRL 43694, does not compromise the efficacy of cisplatin in tumour-bearing mice. Cancer Chemotherapy and Pharmacology. 25(5). 377–379. 6 indexed citations

17.

Rowlands, Martin, Iris B. Parr, Raymond McCague, Michael Jarman, & Phyllis M. Goddard. (1990). Variation of the inhibition of calmodulin dependent cyclic AMP phosphodiesterase amongst analogues of tamoxifen; Correlations with cytotoxicity. Biochemical Pharmacology. 40(2). 283–289. 70 indexed citations

18.

Giraldi, Tullio, et al.. (1980). Antitumor Activity of Hydrazones and Adducts between Aromatic Aldehydes and P-(3,3-dimethyl-1-triazeno)benzoic Acid Hydrazide. Journal of Pharmaceutical Sciences. 69(1). 97–98. 13 indexed citations

19.

Giraldi, Tullio, et al.. (1977). Preparation and antitumor activity of 1-aryl-3,3-dimethyltriazene derivatives. Journal of Medicinal Chemistry. 20(6). 850–853. 21 indexed citations

20.

Connors, T.A., et al.. (1976). Tumour inhibitory triazenes: Structural requirements for an active metabolite. Biochemical Pharmacology. 25(3). 241–246. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact